Here we describe a mutant form of Cbl-c found in a murine mammary cancer model driven by SV40 Large T antigen and demonstrate that the mutant protein lacks E3 activity, acts in a dominant negative fashion to prevent ubiquitination of activated EGFR by wild type Cbl proteins, and can enhance transformation by Large T antigen. This evidence concerns the gene CBLC and breast cancer.